nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—CARTPT—nerve—restless legs syndrome	0.138	0.164	CbGeAlD
Amphetamine—CARTPT—Circadian rythm related genes—BTBD9—restless legs syndrome	0.103	0.656	CbGpPWpGaD
Amphetamine—CARTPT—brainstem—restless legs syndrome	0.0594	0.0704	CbGeAlD
Amphetamine—SLC6A2—autonomic nervous system—restless legs syndrome	0.051	0.0604	CbGeAlD
Amphetamine—CARTPT—spinal cord—restless legs syndrome	0.0369	0.0438	CbGeAlD
Amphetamine—SLC6A3—nerve—restless legs syndrome	0.0356	0.0421	CbGeAlD
Amphetamine—TAAR1—nervous system—restless legs syndrome	0.0311	0.0369	CbGeAlD
Amphetamine—CARTPT—nervous system—restless legs syndrome	0.0311	0.0369	CbGeAlD
Amphetamine—MAOB—nerve—restless legs syndrome	0.031	0.0367	CbGeAlD
Amphetamine—TAAR1—central nervous system—restless legs syndrome	0.03	0.0355	CbGeAlD
Amphetamine—CARTPT—central nervous system—restless legs syndrome	0.03	0.0355	CbGeAlD
Amphetamine—SLC6A2—nerve—restless legs syndrome	0.0287	0.034	CbGeAlD
Amphetamine—DRD2—nerve—restless legs syndrome	0.0261	0.031	CbGeAlD
Amphetamine—CARTPT—brain—restless legs syndrome	0.0238	0.0282	CbGeAlD
Amphetamine—SLC18A2—brainstem—restless legs syndrome	0.0202	0.0239	CbGeAlD
Amphetamine—SLC6A3—brainstem—restless legs syndrome	0.0153	0.0181	CbGeAlD
Amphetamine—SLC6A4—brainstem—restless legs syndrome	0.014	0.0166	CbGeAlD
Amphetamine—MAOB—brainstem—restless legs syndrome	0.0133	0.0158	CbGeAlD
Amphetamine—SLC6A2—brainstem—restless legs syndrome	0.0123	0.0146	CbGeAlD
Amphetamine—DRD2—brainstem—restless legs syndrome	0.0112	0.0133	CbGeAlD
Amphetamine—SLC18A2—nervous system—restless legs syndrome	0.0106	0.0125	CbGeAlD
Amphetamine—SLC6A4—Circadian rythm related genes—BTBD9—restless legs syndrome	0.0103	0.0659	CbGpPWpGaD
Amphetamine—SLC18A2—central nervous system—restless legs syndrome	0.0102	0.0121	CbGeAlD
Amphetamine—SLC6A3—spinal cord—restless legs syndrome	0.00949	0.0112	CbGeAlD
Amphetamine—SLC6A4—spinal cord—restless legs syndrome	0.0087	0.0103	CbGeAlD
Amphetamine—MAOB—spinal cord—restless legs syndrome	0.00827	0.0098	CbGeAlD
Amphetamine—SLC18A2—brain—restless legs syndrome	0.00808	0.00958	CbGeAlD
Amphetamine—SLC6A3—nervous system—restless legs syndrome	0.008	0.00948	CbGeAlD
Amphetamine—SLC6A3—central nervous system—restless legs syndrome	0.0077	0.00913	CbGeAlD
Amphetamine—SLC22A3—nervous system—restless legs syndrome	0.00753	0.00892	CbGeAlD
Amphetamine—SLC6A4—nervous system—restless legs syndrome	0.00733	0.00869	CbGeAlD
Amphetamine—SLC22A3—central nervous system—restless legs syndrome	0.00725	0.00859	CbGeAlD
Amphetamine—CYP2A6—brain—restless legs syndrome	0.00722	0.00855	CbGeAlD
Amphetamine—SLC6A4—central nervous system—restless legs syndrome	0.00705	0.00836	CbGeAlD
Amphetamine—MAOB—nervous system—restless legs syndrome	0.00697	0.00826	CbGeAlD
Amphetamine—CYP2D6—brainstem—restless legs syndrome	0.00674	0.00799	CbGeAlD
Amphetamine—MAOB—central nervous system—restless legs syndrome	0.00671	0.00795	CbGeAlD
Amphetamine—SLC22A5—spinal cord—restless legs syndrome	0.0065	0.0077	CbGeAlD
Amphetamine—SLC6A2—nervous system—restless legs syndrome	0.00645	0.00765	CbGeAlD
Amphetamine—DRD2—Circadian rythm related genes—BTBD9—restless legs syndrome	0.00631	0.0403	CbGpPWpGaD
Amphetamine—SLC6A2—central nervous system—restless legs syndrome	0.00621	0.00736	CbGeAlD
Amphetamine—SLC6A3—brain—restless legs syndrome	0.00611	0.00724	CbGeAlD
Amphetamine—DRD2—nervous system—restless legs syndrome	0.00588	0.00697	CbGeAlD
Amphetamine—SLC22A3—brain—restless legs syndrome	0.00575	0.00682	CbGeAlD
Amphetamine—DRD2—central nervous system—restless legs syndrome	0.00566	0.00671	CbGeAlD
Amphetamine—SLC6A4—brain—restless legs syndrome	0.0056	0.00664	CbGeAlD
Amphetamine—MAOB—brain—restless legs syndrome	0.00533	0.00631	CbGeAlD
Amphetamine—SLC6A2—brain—restless legs syndrome	0.00493	0.00584	CbGeAlD
Amphetamine—DRD2—brain—restless legs syndrome	0.00449	0.00533	CbGeAlD
Amphetamine—SLC22A5—brain—restless legs syndrome	0.00418	0.00496	CbGeAlD
Amphetamine—CYP2D6—nervous system—restless legs syndrome	0.00353	0.00419	CbGeAlD
Amphetamine—CYP2D6—central nervous system—restless legs syndrome	0.0034	0.00403	CbGeAlD
Amphetamine—TAAR1—G alpha (s) signalling events—POMC—restless legs syndrome	0.00331	0.0212	CbGpPWpGaD
Amphetamine—CYP2D6—brain—restless legs syndrome	0.0027	0.0032	CbGeAlD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.00266	0.017	CbGpPWpGaD
Amphetamine—MAOB—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.00239	0.0153	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.0023	0.0147	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.00229	0.0147	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TF—restless legs syndrome	0.00228	0.0146	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.00179	0.0115	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.00159	0.0101	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—POMC—restless legs syndrome	0.00158	0.0101	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAP2K5—restless legs syndrome	0.00148	0.00948	CbGpPWpGaD
Amphetamine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.00144	0.00919	CbGpPWpGaD
Amphetamine—MAOB—Biological oxidations—POMC—restless legs syndrome	0.00127	0.00812	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—POMC—restless legs syndrome	0.0012	0.00769	CbGpPWpGaD
Amphetamine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.00116	0.00745	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—TF—restless legs syndrome	0.000985	0.0063	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—TF—restless legs syndrome	0.000852	0.00545	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—TF—restless legs syndrome	0.000849	0.00543	CbGpPWpGaD
Amphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000806	0.00515	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—POMC—restless legs syndrome	0.00068	0.00435	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—TF—restless legs syndrome	0.000663	0.00424	CbGpPWpGaD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000653	0.00418	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—POMC—restless legs syndrome	0.000619	0.00396	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—POMC—restless legs syndrome	0.000617	0.00395	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—TF—restless legs syndrome	0.000587	0.00376	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—POMC—restless legs syndrome	0.000463	0.00296	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—restless legs syndrome	0.000368	0.00236	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—POMC—restless legs syndrome	0.000365	0.00233	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—POMC—restless legs syndrome	0.000347	0.00222	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAP2K5—restless legs syndrome	0.000346	0.00221	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—POMC—restless legs syndrome	0.000281	0.00179	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—restless legs syndrome	0.000217	0.00139	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—restless legs syndrome	0.000184	0.00118	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—restless legs syndrome	0.000159	0.00101	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—restless legs syndrome	0.000144	0.000921	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—restless legs syndrome	0.000106	0.000677	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—restless legs syndrome	8.5e-05	0.000544	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—restless legs syndrome	5.93e-05	0.00038	CbGpPWpGaD
